Drugs / autologous CD133+ cells
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00913900 Comparator | May 2009 → Dec 2013 | arterial occlusion, limb ischemia | University of Wisconsin, Madison | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous CD133+ cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00913900 ↗ |
| Modality | Cell therapy | “Adult stem cells injected into affected legs” NCT00913900 ↗ |
| Route | Intramuscular | “intramuscular administration of 50-400 million sorted CD133+ cells” PMID 25239491 ↗ Sep 2014 |